We report right here on HIV-1 immunization leads to rabbits and macaques co-immunized with clade C gp160 DNA and gp140 trimeric envelope vaccines, a method just like a latest medical trial that confirmed improved pace and magnitude of humoral responses.
Clade C envelopes had been remoted from CAP257, a person who developed a novel temporal sample of neutralization breadth improvement, comprising three separate “Waves” focusing on distinct Env epitopes and completely different HIV clades. We used phylogeny and neutralization standards to down-select envelope vaccine candidates, and confirmed antigenicity of our antigens by interplay with well-characterized broadly neutralizing monoclonal antibodies. Utilizing these envelopes, we carried out rabbit research that screened for immunogenicity of CAP257 Envs from timepoints previous peak neutralization breadth in every Wave. Chosen CAP257 envelopes from Waves 1 and a pair of, in the course of the first 2 years of an infection that had been extremely immunogenic in rabbits had been then examined in macaques.
We discovered that in rabbits and macaques, co-immunization of DNA, and protein envelope-based vaccines induced most binding and neutralizing antibody titers with three immunizations. No additional profit was obtained with extra immunizations. The vaccine methods recapitulated the Wave-specific epitope focusing on noticed within the CAP257 participant, and elicited Tier 1A, 1B, and Tier 2 heterologous neutralization. CAP257 envelope immunogens additionally induced the event of ADCC and TFH responses in macaques, and these responses positively correlated with heterologous neutralization.
Collectively, the outcomes from two animal fashions on this research have implications for figuring out efficient vaccine immunogens. We used a multi-step technique to (1) choose an Env donor with well-characterized neutralization breadth improvement; (2) research Env phylogeny for potential immunogens circulating close to peak breadth timepoints in the course of the first 2 years of an infection; (3) check down-selected Envs for antigenicity; (4) display down-selected Envs in an efficient vaccine routine in rabbits; and (5) advance essentially the most immunogenic Envs to NHP research.
PSMB9 Antibody |
32427 |
SAB |
100ul |
EUR 439 |
PSMB9 Antibody |
32427-100ul |
SAB |
100ul |
EUR 302.4 |
PSMB9 Antibody |
E91771 |
EnoGene |
100ul |
EUR 255 |
Description: Available in various conjugation types. |
PSMB9 Antibody |
E307756 |
EnoGene |
200ul |
EUR 275 |
Description: Available in various conjugation types. |
PSMB9 antibody |
70R-5740 |
Fitzgerald |
50 ug |
EUR 467 |
|
Description: Rabbit polyclonal PSMB9 antibody raised against the C terminal of PSMB9 |
PSMB9 antibody |
70R-19590 |
Fitzgerald |
50 ul |
EUR 289 |
|
Description: Rabbit polyclonal PSMB9 antibody |
PSMB9 Antibody |
1-CSB-PA018887GA01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against PSMB9. Recognizes PSMB9 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
PSMB9 Antibody |
1-CSB-PA018887LA01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against PSMB9. Recognizes PSMB9 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:5000, IHC:1:200-1:500 |
PSMB9 Antibody |
R35691-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
|
Description: Additional name(s) for this target protein: Proteasome beta 9 |
PSMB9 Conjugated Antibody |
C32427 |
SAB |
100ul |
EUR 476.4 |
PSMB9 Polyclonal Antibody |
E-AB-60439-120uL |
Elabscience Biotech |
120uL |
EUR 320 |
|
Description: Unconjugated |
PSMB9 Polyclonal Antibody |
E-AB-60439-200uL |
Elabscience Biotech |
200uL |
EUR 530 |
|
Description: Unconjugated |
PSMB9 Polyclonal Antibody |
E-AB-60439-60uL |
Elabscience Biotech |
60uL |
EUR 200 |
|
Description: Unconjugated |
PSMB9 Polyclonal Antibody |
E-AB-60439-each |
Elabscience Biotech |
each |
Ask for price |
|
Description: Unconjugated |
PSMB9 Antibody, HRP conjugated |
1-CSB-PA018887LB01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against PSMB9. Recognizes PSMB9 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
PSMB9 Antibody, FITC conjugated |
1-CSB-PA018887LC01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against PSMB9. Recognizes PSMB9 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
PSMB9 Antibody, Biotin conjugated |
1-CSB-PA018887LD01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against PSMB9. Recognizes PSMB9 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
PSMB9 Rabbit Polyclonal Antibody |
E10G33024 |
EnoGene |
100 μl |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Polyclonal PSMB9 Antibody (C-Term) |
APR04883G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PSMB9 (C-Term). This antibody is tested and proven to work in the following applications: |
Polyclonal PSMB9 Antibody (C-term) |
APR06094G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PSMB9 (C-term). This antibody is tested and proven to work in the following applications: |
Polyclonal PSMB9 Antibody (C-term) |
APR06933G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PSMB9 (C-term). This antibody is tested and proven to work in the following applications: |
Polyclonal PSMB9 Antibody (internal region) |
APG00705G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human PSMB9 (internal region). This antibody is tested and proven to work in the following applications: |
PSMB9 Antibody / Proteasome subunit beta type-9 |
F54978-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
Description: PSMB9 is a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. This subunit is involved in antigen processing to generate class I binding peptides. |
PSMB9 Antibody / Proteasome subunit beta type-9 |
F54978-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
|
Description: PSMB9 is a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. This subunit is involved in antigen processing to generate class I binding peptides. |
Proteasome Subunit Beta Type-9 (PSMB9) Antibody |
abx431392-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
Proteasome Subunit Beta Type-9 (PSMB9) Antibody |
20-abx141629 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Proteasome Subunit Beta Type-9 (PSMB9) Antibody |
abx122051-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
Proteasome Subunit Beta Type-9 (PSMB9) Antibody |
20-abx114777 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Proteasome Subunit Beta Type-9 (PSMB9) Antibody |
20-abx001469 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Proteasome Subunit Beta Type-9 (PSMB9) Antibody |
abx001469-100l |
Abbexa |
100 µl |
EUR 400 |
Proteasome Subunit Beta Type-9 (PSMB9) Antibody |
abx001469-20l |
Abbexa |
20 µl |
EUR 175 |
Proteasome Subunit Beta Type-9 (PSMB9) Antibody |
abx001469-50l |
Abbexa |
50 µl |
EUR 275 |
Proteasome Subunit Beta Type-9 (PSMB9) Antibody |
abx114777-100l |
Abbexa |
100 µl |
EUR 612.5 |
Proteasome Subunit Beta Type-9 (PSMB9) Antibody |
abx122051-100l |
Abbexa |
100 µl |
Ask for price |
Proteasome Subunit Beta Type-9 (PSMB9) Antibody |
abx122051-20l |
Abbexa |
20 µl |
EUR 337.5 |
Proteasome Subunit Beta Type-9 (PSMB9) Antibody |
abx122051-50l |
Abbexa |
50 µl |
Ask for price |
Proteasome Subunit Beta Type-9 (PSMB9) Antibody |
abx431392-200l |
Abbexa |
200 µl |
EUR 387.5 |
Proteasome subunit beta type-9 (PSMB9) Antibody |
abx344241-100g |
Abbexa |
100 µg |
EUR 362.5 |
Proteasome subunit beta type-9 (PSMB9) Antibody |
abx344241-20g |
Abbexa |
20 µg |
EUR 162.5 |
Proteasome subunit beta type-9 (PSMB9) Antibody |
abx344241-50g |
Abbexa |
50 µg |
EUR 250 |
ARP46081_P050-25UL - PSMB9 Antibody - C-terminal region |
ARP46081_P050-25UL |
Aviva Systems Biology |
25ul |
EUR 99 |
|
ARP46081_P050 - PSMB9 antibody - C-terminal region (ARP46081_P050) |
ARP46081_P050 |
Aviva Systems Biology |
100ul |
EUR 389 |
|
Proteasome subunit beta type-9 (PSMB9) Antibody (HRP) |
abx344242-100g |
Abbexa |
100 µg |
EUR 362.5 |
Proteasome subunit beta type-9 (PSMB9) Antibody (HRP) |
abx344242-20g |
Abbexa |
20 µg |
EUR 162.5 |
The outcomes had been an induction of excessive titers of HIV-1 envelope-specific antibodies with rising avidity and cross-clade neutralizing antibodies with effector features that collectively might enhance the potential for defense in a pre-clinical SHIV mannequin.
Key phrases: ADCC; HIV vaccine; NHP; TFH responses; co-immunization; envelope immunogen; neutralizing antibodies; rabbit.
Synergistic antitumor exercise of a DLL4/VEGF bispecific therapeutic antibody together with irinotecan in gastric most cancers
PSMB8 Antibody |
1-CSB-PA775839 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
PSMB8 Antibody |
E043134 |
EnoGene |
100μg/100μl |
EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
1-CSB-PA018886GA01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
PSMB8 Antibody |
1-CSB-PA018886LA01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
PSMB8 Antibody |
E94054 |
EnoGene |
100μg |
EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
E97340 |
EnoGene |
100ul |
EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
E314816 |
EnoGene |
100ug/200ul |
EUR 295 |
Description: Available in various conjugation types. |
PSMB8 antibody |
70R-13550 |
Fitzgerald |
100 ul |
EUR 550 |
|
Description: Affinity purified Rabbit polyclonal PSMB8 antibody |
PSMB8 antibody |
70R-19589 |
Fitzgerald |
50 ul |
EUR 289 |
|
Description: Rabbit polyclonal PSMB8 antibody |
PSMB8 Antibody |
1-CSB-PA116429 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
PSMB8 Conjugated Antibody |
C43134 |
SAB |
100ul |
EUR 476.4 |
PSMB8 Polyclonal Antibody |
A73468 |
EpiGentek |
50 μl |
EUR 557 |
PSMB8 Polyclonal Antibody |
E-AB-92394-120uL |
Elabscience Biotech |
120uL |
EUR 320 |
|
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
E-AB-92394-200uL |
Elabscience Biotech |
200uL |
EUR 530 |
|
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
E-AB-92394-60uL |
Elabscience Biotech |
60uL |
EUR 200 |
|
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
E-AB-92394-each |
Elabscience Biotech |
each |
Ask for price |
|
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
E-AB-61655-120uL |
Elabscience Biotech |
120uL |
EUR 320 |
|
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
E-AB-61655-200uL |
Elabscience Biotech |
200uL |
EUR 530 |
|
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
E-AB-61655-60uL |
Elabscience Biotech |
60uL |
EUR 200 |
|
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
E-AB-61655-each |
Elabscience Biotech |
each |
Ask for price |
|
Description: Unconjugated |
PSMB8 Antibody, HRP conjugated |
1-CSB-PA018886LB01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
PSMB8 Antibody, FITC conjugated |
1-CSB-PA018886LC01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
PSMB8 Antibody, Biotin conjugated |
1-CSB-PA018886LD01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
PSMB8 Rabbit Polyclonal Antibody |
55187 |
SAB |
100ul |
EUR 439 |
PSMB8 Rabbit Polyclonal Antibody |
E10G05021 |
EnoGene |
100 μl |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
PSMB8 Rabbit Polyclonal Antibody |
E10G11908 |
EnoGene |
100 μl |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Monoclonal PSMB8 Antibody, Clone: 1A5 |
AMM02864G |
Leading Biology |
0.1ml |
EUR 633.6 |
Description: A Monoclonal antibody against Human PSMB8. The antibodies are raised in Mouse and are from clone 1A5. This antibody is applicable in WB and IHC, ICC, E |
Mouse Monoclonal Antibody to PSMB8 |
E10-30255 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx011689-100g |
Abbexa |
100 µg |
Ask for price |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx011689-10g |
Abbexa |
10 µg |
EUR 362.5 |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx011689-200g |
Abbexa |
200 µg |
Ask for price |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx006453-100g |
Abbexa |
100 µg |
EUR 275 |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx006453-10g |
Abbexa |
10 µg |
EUR 175 |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx006453-200g |
Abbexa |
200 µg |
EUR 387.5 |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx114776-100l |
Abbexa |
100 µl |
EUR 612.5 |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx211178-100l |
Abbexa |
100 µl |
EUR 350 |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx211178-50l |
Abbexa |
50 µl |
EUR 250 |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx211851-100l |
Abbexa |
100 µl |
EUR 350 |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx211851-50l |
Abbexa |
50 µl |
EUR 250 |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx028154-400l |
Abbexa |
400 µl |
EUR 518.75 |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx234811-100g |
Abbexa |
100 µg |
EUR 350 |
Proteasome Subunit Beta Type 8 (PSMB8) Antibody |
abx431393-200l |
Abbexa |
200 µl |
EUR 387.5 |
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
20-abx141396 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
20-abx114776 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
20-abx006453 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
abx028154-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
abx028154-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
abx011689-100ul |
Abbexa |
100 ul |
EUR 493.2 |
|
Proteasome subunit beta type-8 (PSMB8) Antibody |
20-abx211178 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Proteasome subunit beta type-8 (PSMB8) Antibody |
20-abx211851 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Proteasome subunit beta type-8 (PSMB8) Antibody |
abx344237-100l |
Abbexa |
100 µl |
EUR 350 |
Proteasome subunit beta type-8 (PSMB8) Antibody |
abx344237-50l |
Abbexa |
50 µl |
EUR 250 |
Monoclonal PSMB8 Antibody (monoclonal) (M01), Clone: 1B3 |
AMM03954G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A Monoclonal antibody against Human PSMB8 (monoclonal) (M01). The antibodies are raised in Mouse and are from clone 1B3. This antibody is applicable in WB, IHC and IF, IP, E |
Notch signaling has been recognized as a vital pathway in gastric most cancers (GC) development and metastasis, and inhibition of Delta-like ligand 4 (DLL4), a Notch ligand, is usually recommended as a potent therapeutic strategy for GC. Expression of each DLL4 and vascular endothelial development issue receptor 2 (VEGFR2) was related within the malignant tissues of GC sufferers.
-
- We centered on vascular endothelial development issue (VEGF), a recognized angiogenesis regulator and activator of DLL4. Right here, we used ABL001, a DLL4/VEGF bispecific therapeutic antibody, and investigated its therapeutic impact in GC.
-
- Remedy with human DLL4 therapeutic antibody (anti-hDLL4) or ABL001 barely diminished GC cell development in monolayer tradition; nonetheless, they considerably inhibited cell development in 3D-culture, suggesting a discount within the most cancers stem cell inhabitants. Remedy with anti-hDLL4 or ABL001 additionally decreased GC cell migration and invasion.
-
- Furthermore, the mixed therapy of irinotecan with anti-hDLL4 or ABL001 confirmed synergistic antitumor exercise. Each mixture remedies additional diminished cell development in 3D-culture in addition to cell invasion. Apparently, the mix therapy of ABL001 with irinotecan synergistically diminished the GC burden in each xenograft and orthotopic mouse fashions.
- Collectively, DLL4 inhibition considerably decreased cell motility and stem-like phenotype and the mix therapy of DLL4/VEGF bispecific therapeutic antibody with irinotecan synergistically diminished the GC burden in mouse fashions. Our information recommend that ABL001 doubtlessly represents a potent agent in GC remedy. Additional biochemical and pre-clinical research are wanted for its software within the clinic.